Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study

BACKGROUND: Benefits using the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness of PCV13 vaccination in preventing hospitalisation from pneumonia among middle-aged and older adults. METHODS: Population-based cohort study inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Vila-Corcoles, Angel, Ochoa-Gondar, Olga, de Diego, Cinta, Satue, Eva, Aragón, María, Vila-Rovira, Angel, Gomez-Bertomeu, Frederic, Magarolas, Ramon, Figuerola-Massana, Enric, Raga, Xavier, Perez, Mar O., Ballester, Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921259/
https://www.ncbi.nlm.nih.gov/pubmed/29699550
http://dx.doi.org/10.1186/s12879-018-3096-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921259/
https://www.ncbi.nlm.nih.gov/pubmed/29699550
http://dx.doi.org/10.1186/s12879-018-3096-7

Ejemplares similares